MEIRAGTX
Dead / Cancelled — Cancelled — Section 8 (as of 14 Feb 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87304368
- Registration number
- 5527437
- Mark type
- Stylized text
- Filed
- 17 Jan 2017
- Published for opposition
- 15 May 2018
- Registered
- 31 Jul 2018
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 001 — Chemicals: Chemical additives, namely, chemical auxiliary agents, carriers and substances for use in the manufacture of pharmaceutical preparations
- Class 005 — Pharmaceuticals: Pharmaceutical products for use in gene therapy; pharmaceutical and biological preparations for the treatment of neurological and neurodegerative diseases, ocular diseases and rare diseases, in the nature of rare kidney diseases, rare cardiovascular diseases, rare hepato-gastro-enterological diseases, rare immunodeficiencies, developmental defects, neuromuscular diseases, rare neurological diseases, rare cardiovascular diseases, rare lung diseases, rare bone diseases, rare sensory disorders, rare skin diseases, rare diseases of connective tissue, rare endocrine diseases, rare hereditary metabolic diseases, rare nonmalignant hematologic disorders; pharmaceutical preparations, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; dermatological pharmaceutical products; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases
- Class 040 — Treatment of materials: Custom manufacture of human therapeutics, pharmaceuticals, biologicals and biopharmaceuticals
- Class 042 — Scientific and technological services: Scientific research in the field of genetics, gene therapy and genetic engineering; Genetic testing for scientific research purposes; scientific advisory services relating to gene therapy research; Scientific, biological, pharmaceutical and medical research and services; laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; biochemical and biotechnological analysis and services
Owner
- MeiraGTx Limited, London, GB
- MeiraGTx Limited, London, GB
- MeiraGTx Limited, London, GB
Prosecution history
- 14 Feb 2025 — CANCELLED SEC. 8 (6-YR)
- 31 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 15 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 May 2018 — PUBLISHED FOR OPPOSITION
- 25 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Apr 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Apr 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Apr 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Apr 2018 — ASSIGNED TO LIE
- 23 Mar 2018 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 25 Oct 2017 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 25 Oct 2017 — FINAL REFUSAL E-MAILED
- 25 Oct 2017 — FINAL REFUSAL WRITTEN
- 06 Oct 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED